As spatial biology rapidly integrates into immuno-oncology, it is fundamentally reshaping our understanding of tumor-immune interactions. Recent breakthroughs in imaging and molecular profiling technologies are providing unprecedented insights into the tumor microenvironment (TME), enabling researchers to identify critical immune subpopulations and discover novel biomarkers with remarkable precision. This transformative approach not only enhances our understanding of cancer biology but also paves the way for the development of more effective and personalized immunotherapies.
As we stand at the forefront of this transformation, critical questions still persist:
How Do We Integrate Spatial Data Into Clinical Workflows?
How Can Organizations Create a Business Case for These Innovations That Is Both Cost-Effective and Time-Efficient?
What Computational Tools Are Necessary to Decode Complex Datasets?
Returning in 2025, the 3rd Spatial Biology for Immuno-Oncology Summit offers a unique platform for you and your peers to address these pressing challenges. Engage with global experts from Pathology, Computational Biology, Bioinformatics, and Translation to uncover practical case studies that showcase the successful application of spatial biology in immuno-oncology.
Join us at this industry-focused forum to learn from leaders who are already harnessing spatial technologies to develop cutting-edge solutions and enhance drug development workflows. Be part of the conversation that will shape the future of oncology.
Sessions Snapshot
Utilize spatial technologies to generate comprehensive tissue expression profiles, enabling precise spatial mapping of molecular targets with Johnson & Johnson
Distill biological insights from complex spatial omics data using data analytics techniques with Eli Lilly & Co.
Explore how spatial data informs key decisions on balancing evidence generation with the costs of drug development, identifying when and how much to invest for optimal outcomes with Amgen
Assess the strengths and weaknesses of building external and internal spatial biology capabilities to ensure informed resource allocation with AbbVie & Pfizer
Leverage AI techniques for identifying complex patterns and relationships within spatial data with Genentech
Expert Speakers Snapshot
Hua Gong
Senior Vice President, Global Head of Translational Medicine & Clinical Biomarkers
Zai Laboratory
Who's Previously Attended?
What They Said
“There was a tremendous amount of interaction and engagement between the audience and speakers. It had a wonderful think tank atmosphere” MEI Pharma
“Open discussion with honest insights, some leaders in the field really speak up for the true issues and potential solution, enjoyed the whole thing, it is very valuable for the whole community!” Pfizer
“The content and agenda were very solid. I Enjoyed interacting with peers and sharing our work” AbbVie
“Excellent collection of speakers, great opportunities for networking” Arcus Biosciences
“Wide perspective on the entire field of spatial biology with a high level of science and technology covered” Takeda